# Intraoral 30% Glucose Effect In Newborns

> **NCT02325583** · PHASE3 · COMPLETED · sponsor: **Baskent University** · enrollment: 19 (actual)

## Conditions studied

- Epilepsy
- Hydrocephaly

## Interventions

- **DRUG:** 30% Glucose
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT02325583
- **Lead sponsor:** Baskent University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02325583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02325583, "Intraoral 30% Glucose Effect In Newborns". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02325583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*